Metacrine Inc

NASDAQ:MTCR   4:00:00 PM EDT
0.41
0.00 (-1.20%)
Earnings Announcements

Metacrine Inc Cash And Cash Equivalents Were $52.8 Million As Of Sept. 30

Published: 11/14/2022 23:11 GMT
Metacrine Inc (MTCR) - Metacrine Inc - Cash and Cash Equivalents Were $52.8 Million As of September 30, 2022.
Metacrine Inc - Net Loss Was $5.5 Million for the Three Months Ended September 30, 2022.
Metacrine Inc - Believes It Has Sufficient Capital to Fund Its Current Operating Plan Through at Least 2023.
Further Company Coverage: Mtcro ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.